Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Molecular Diagnostics Market Forecast 2028 By Technology (Polymerase Chain Reaction [PCR], Hybridization, Sequencing, Isothermal Nucleic Acid Amplification Technology [INAAT], Microarrays), By Product (Instruments, Reagents & Kits), By Application (Infectious Disease Diagnostics {COVID-19, HIV, CT/NG, Hepatitis B, Hepatitis C, RSV, Flu, Tuberculosis}, Oncology Testing, Genetic Disease Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: August 2022   |   Report ID: GR1143   |   Delivery: PDF  Request Free Sample

    North America Molecular Diagnostics Market size exceeded USD 10.52 billion in 2021 and is anticipated to expand at a CAGR of 2% from 2022 to 2028.

    Early detection is adopted as a proven strategy for the effective treatment of chronic and infectious diseases. In North American countries, genetic testing and the diagnosis of syphilis, HIV, and other sexually transmitted diseases have increased considerably. This factor, alongside the growing awareness of early disease diagnosis, will escalate the requirement for molecular diagnostics.

    North America Molecular Diagnostics Market

    Get more details on this report - Request Free Sample PDF

    Some of the major applications using molecular diagnostics include drug regimen selection, therapeutic monitoring, and patient stratification. Likewise, research and development programs and deployment of automation technologies are emerging as prominent trends favoring the industry outlook.

    Over the years, developments in nucleic acid amplification and single pathogen detection methods to offer accurate and faster results have been witnessed. However, the introduction of stringent regulations may create a hindrance to the regional industry expansion.

    Impact of COVID-19 on the North America Molecular Diagnostics Industry Dynamics

    In the wake of the COVID-19 pandemic, the need for reagents and kits for effective diagnostic testing has surged considerably. To address this burgeoning demand, in August 2021, the DoD (Department of Defense) awarded a contract worth $0.6 million to QIAGEN Beverly, Inc. to boost the manufacturing capacity of enzymatic reagents and kits for use in COVID-19 molecular diagnostic tests. This expansion effort was intended to allow the company to increase the production of reagent kits by over 7,000 per month in its Massachusetts, facility by February 2022 end.

    North America Market, By Product

    The instruments segment accounted for USD 2,840 million revenue in 2021, attributed to rapid technological advancements and the widespread usage of molecular diagnostics in microfluidic devices as an effective approach for pathogen detection.

    North America Market, By End-use

    The diagnostic laboratories segment will witness substantial growth through 2028, led by the mounting investment in lab expansion projects in countries including the U.S. For example, in April 2022, Mayo Clinic announced an investment in a major laboratory expansion project in Rochester to support patient care service delivery.

    North America Market, By Application

    The infectious disease testing segment will gain remarkable momentum during the forecast timeline, credited to the escalating number of elderly people who are at high risk of chronic infections. North America also witnesses a high prevalence of tuberculosis. These factors, along with the favorable reimbursement scenario, will boost the popularity of molecular diagnostics across the region.

    North America Market, By Country

    Canada molecular diagnostics market revenue will increase exponentially till 2028, driven by the escalating geriatric population and the high burden of chronic diseases such as diabetes. According to the 2021 census data, the number of people aged over 85 years and above increased by 12% since 2016, which is more than twice the overall increase in the Canadian population at 5.2%.

    Competitive Industry Landscape

    Major players involved in the North America market include Roche Diagnostics, Johnson & Johnson, Danaher, Cephied, BioRad Laboratories, Biomerieux, Becton Dickinson, Analytik Jena, Alere, Agilent (Dako), and Abbott Molecular. These companies are emphasizing new product launches, mergers, acquisitions, and other strategies to increase their customer base and expand their footprint in the market.

    Frequently Asked Question(FAQ) :

    How much growth rate will the molecular diagnostics industry exhibit in North America?
    The market for molecular diagnostics in North America was registered revenue of around USD 10,520 million in 2021 and is poised to depict a CAGR of nearly 2% from 2022 to 2028.
    Why is the demand for molecular diagnostics instruments rising in North America?
    The instruments segment registered revenue of nearly USD 2,840 million in 2021, which was as attributable to rapid technological advancements.
    What factors are proliferating the Canada molecular diagnostics market share?
    The industry share for molecular diagnostics in Canada will rise considerably through 2028, owing to the escalating geriatric population and the high burden of chronic diseases.
    Which companies are operating in the North America molecular diagnostics landscape?
    Prominent companies in the market include Roche Diagnostics, Johnson & Johnson, Danaher, Cephied, BioRad Laboratories, Biomerieux, Becton Dickinson, Analytik Jena, Alere, Agilent (Dako), Abbott Molecular, and others.

    Get this research report on North America Molecular Diagnostics Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]